Crossmark

Predictors of early high-level response to bimekizumab in patients with moderate-to-severe plaque psoriasis: a real-world cohort study

Crossref DOI link: https://doi.org/10.1016/j.abd.2026.501353

Published Print: 2026-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Engin, Burhan https://orcid.org/0000-0002-5140-1926
Demir, Yusuf

Yildirim, Gurbuz

Diken, Fatma Zehra

Yildiz, Bengusu

Kutlubay, Zekayi

Serdaroglu, Server
License Information

Text and Data Mining valid from 2026-05-01

Text and Data Mining valid from 2026-05-01

Version of Record valid from 2026-04-02
More Information

This article is maintained by: Elsevier

Article Title: Predictors of early high-level response to bimekizumab in patients with moderate-to-severe plaque psoriasis: a real-world cohort study

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2026.501353

Content Type: article

Copyright: © 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.